MX4911E - Procedimiento para preparar derivados de quinoleina - Google Patents

Procedimiento para preparar derivados de quinoleina

Info

Publication number
MX4911E
MX4911E MX775818U MX581877U MX4911E MX 4911 E MX4911 E MX 4911E MX 775818 U MX775818 U MX 775818U MX 581877 U MX581877 U MX 581877U MX 4911 E MX4911 E MX 4911E
Authority
MX
Mexico
Prior art keywords
preparing
procedure
quinolein
derivatives
quinolein derivatives
Prior art date
Application number
MX775818U
Other languages
English (en)
Spanish (es)
Inventor
Alain Champseix
Claude Gueremy
Gerard Lefur
Original Assignee
Mar Pha Etu Expl Marques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mar Pha Etu Expl Marques filed Critical Mar Pha Etu Expl Marques
Publication of MX4911E publication Critical patent/MX4911E/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
MX775818U 1976-06-18 1977-06-16 Procedimiento para preparar derivados de quinoleina MX4911E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7618555A FR2354771A1 (fr) 1976-06-18 1976-06-18 ((quinolyl-4)-3 propyl-1) -4 piperidines, leur preparation et leur utilisation comme medicaments

Publications (1)

Publication Number Publication Date
MX4911E true MX4911E (es) 1983-01-03

Family

ID=9174581

Family Applications (1)

Application Number Title Priority Date Filing Date
MX775818U MX4911E (es) 1976-06-18 1977-06-16 Procedimiento para preparar derivados de quinoleina

Country Status (20)

Country Link
JP (1) JPS52156933A (da)
AR (1) AR218452A1 (da)
AT (1) AT358589B (da)
AU (1) AU517786B2 (da)
BE (1) BE855790A (da)
CA (1) CA1106379A (da)
CH (1) CH625800A5 (da)
DE (1) DE2727144C3 (da)
DK (1) DK268777A (da)
ES (1) ES459903A1 (da)
FR (1) FR2354771A1 (da)
GB (1) GB1546537A (da)
GR (1) GR61990B (da)
HU (1) HU179758B (da)
IL (1) IL52329A (da)
IT (1) IT1082822B (da)
LU (1) LU77548A1 (da)
MX (1) MX4911E (da)
NL (1) NL7706614A (da)
ZA (1) ZA773643B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2432518A2 (fr) * 1978-08-03 1980-02-29 Pharmindustrie Derives de la ((quinolyl-4)-3 propyl-1)-4 piperidine utilisables comme medicaments
GR69926B (da) * 1978-03-23 1982-07-21 Pharmindustrie
FR2448530A1 (fr) * 1979-02-09 1980-09-05 Pharmindustrie Procede de transformation de derives de la vinyl -3 piperidine en leurs epimeres
FR2471981A1 (fr) * 1979-12-21 1981-06-26 Pharmindustrie Nouveaux derives de la (piperidyl-4)-2 (quinolyl-4)-1 ethanone, produits intermediaires et procedes pour leur preparation, et leur utilisation comme medicaments
FR2477544A1 (fr) * 1980-03-07 1981-09-11 Pharmindustrie Nouveaux derives de la chloro-3 quinoleine, procedes pour leur preparation, et leur utilisation comme medicaments
FR2485014A1 (fr) * 1980-06-20 1981-12-24 Pharmindustrie Nouveaux derives de (quinolyl-2, -3 ou -4)-1 (piperidyl ou pyrrolidinyl-2 ou -3)-2 ou -3 ethanone ou propanone, procedes pour leur preparation, et leur utilisation comme medicaments
FR2495470A1 (fr) * 1980-12-05 1982-06-11 Pharmindustrie Nouveaux medicaments a base de derives de (quinolyl-4)-1 (piperidyl-4)-2 ethanol ou (quinolyl-4)-1 (piperidyl-4)-3 propanol
FR2842807A1 (fr) 2002-07-23 2004-01-30 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, procede et intermediaires de preparation et compositions les renfermant
EP1907384A2 (en) * 2005-06-30 2008-04-09 Prosidion Limited Gpcr agonists

Also Published As

Publication number Publication date
AU517786B2 (en) 1981-08-27
JPS52156933A (en) 1977-12-27
DK268777A (da) 1977-12-19
DE2727144A1 (de) 1977-12-29
ZA773643B (en) 1978-05-30
AU2618877A (en) 1978-12-21
JPS6134404B2 (da) 1986-08-07
AR218452A1 (es) 1980-06-13
LU77548A1 (fr) 1979-04-09
GB1546537A (en) 1979-05-23
DE2727144C3 (de) 1980-10-02
IT1082822B (it) 1985-05-21
FR2354771A1 (fr) 1978-01-13
ATA423277A (de) 1980-02-15
ES459903A1 (es) 1978-09-01
CA1106379A (fr) 1981-08-04
IL52329A0 (en) 1977-08-31
DE2727144B2 (de) 1980-02-07
CH625800A5 (en) 1981-10-15
IL52329A (en) 1980-10-26
GR61990B (en) 1979-02-14
HU179758B (en) 1982-12-28
AT358589B (de) 1980-09-25
NL7706614A (nl) 1977-12-20
FR2354771B1 (da) 1982-01-08
BE855790A (fr) 1977-12-19

Similar Documents

Publication Publication Date Title
MX4811E (es) Procedimiento para preparar derivados de prostaglandina
MX4899E (es) Procedimiento para preparar derivados de espirohidantoina
ES488635A0 (es) Procedimiento para preparar derivados de pirimidina
MX4652E (es) Procedimiento para preparar aril-3-oxazolidinonas-2
MX5535E (es) Procedimiento para preparar 2-alfa-ciano-3-oxo-esteroides
ES488772A0 (es) Procedimiento para preparar derivados de pirimidona
MX4883E (es) Procedimiento para preparar amidinoureas
AR221081A1 (es) Procedimiento para preparar derivados de fenoximetil-piperidino-propoxi-indol
MX4597E (es) Procedimiento para preparar gamma-pironas
AR216438A1 (es) Procedimiento para preparar derivados de difenil-alquil-aza-bicicloalcano
MX151851A (es) Procedimiento mejorado para preparar derivados de triacina
MX4594E (es) Procedimiento para preparar combuestos de 3-halometilcefem
AR222453A1 (es) Procedimiento para preparar 3-amino-4-carboxi-tiofenos
MX4911E (es) Procedimiento para preparar derivados de quinoleina
MX4942E (es) Procedimiento para preparar derivados de benzodioxol
MX4711E (es) Procedimiento para preparar derivados-be-n-(1-alil-2-pirrolidilmetil)-2-3-dimetoxi-5-sulfamoilbenzamida
MX4603E (es) Procedimiento para prepara derivados de vincamina
MX5160E (es) Procedimiento mejorado para preparar derivados de aminoalcoholes
MX5434E (es) Procedimiento para preparar cicloprofilcarboxilatos
MX4478E (es) Procedimiento mejorado para la obtencion de derivados de acetanilidotiofosfato
ES492394A0 (es) Procedimiento para preparar derivados de pirimidina
MX5208E (es) Procedimiento para preparar diclorovinilciclobutanonas
MX3964E (es) Procedimiento para preparar oxo-benzopiranos
AR228336A1 (es) Procedimiento para preparar compuestos de 3-clorometilcefem
MX4409E (es) Procedimiento para preparar derivados de cefalosporina